Ownership history in DC Funds, LP · 18 quarters on record
This page tracks every 13F SEC filing in which DC Funds, LP reported a position in TSCAN THERAPEUTICS INC (TCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 630,000 | — | 0% | 43.36% | $630.0M | $1.00 |
| 2025 Q3 | UNCHANGED | 630,000 | — | 0% | 36.87% | $1.15B | $1.82 |
| 2025 Q2 | UNCHANGED | 630,000 | — | 0% | 42.43% | $913.5M | $1.45 |
| 2025 Q1 | UNCHANGED | 630,000 | — | 0% | 42.07% | $869.4M | $1.38 |
| 2024 Q4 | UNCHANGED | 630,000 | — | 0% | 53.75% | $1.92B | $3.04 |
| 2024 Q3 | UNCHANGED | 630,000 | — | 0% | 60.91% | $3.14B | $4.98 |
| 2024 Q2 | UNCHANGED | 630,000 | — | 0% | 61.20% | $3.69B | $5.85 |
| 2024 Q1 | UNCHANGED | 630,000 | — | 0% | 48.34% | $5.0M | $7.94 |
| 2023 Q4 | UNCHANGED | 630,000 | — | 0% | 44.16% | $3.67B | $5.83 |
| 2023 Q3 | UNCHANGED | 630,000 | — | 0% | 33.20% | $1.61B | $2.56 |
As of 2025 Q4 — sorted by position size